Funder
Center for Tobacco Products
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference69 articles.
1. Al-hebshi NN, Alharbi FA, Mahri M, Chen T (2017) Differences in the bacteriome of smokeless tobacco products with different oral carcinogenicity: compositional and predicted functional analysis. Genes 8:106. https://doi.org/10.3390/genes8040106
2. Ayo-Yusuf OA, van Wyk C, van Wyk CW, de Wet I (2005) Smokeless tobacco products on the south African market do not inhibit oral bacterial flora: a pilot study. South Afr J Epidemiol Infect 20:136–139. https://doi.org/10.1080/10158782.2005.11441251
3. Bogden JD, Kemp FW, Buse M, Thind IS, Louria DB, Forgacs J, Llanos G, Moncoya Terrones I (1981) Composition of tobaccos from countries with high and low incidences of lung cancer. I. selenium, polonium-210, alternaria, tar, and nicotine. JNCI: Journal of the National Cancer Institute 66:27–31. https://doi.org/10.1093/jnci/66.1.27
4. (2019) Cigarette Smoking Among U.S. Adults Hits All-Time Low | CDC Online Newsroom | CDC. https://www.cdc.gov/media/releases/2019/p1114-smoking-low.html. Accessed 9 Nov 2020
5. CDC Tobacco Free (2018) 2014 SGR: the health consequences of smoking—50 years of progress. In: Centers for Disease Control and Prevention. https://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm. Accessed 9 Nov 2020
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献